𝔖 Bobbio Scriptorium

✦ LIBER ✦

The Hippo Tumor Suppressor Network: From Organ Size Control to Stem Cells and Cancer

✍ Scribed by Halder, G.; Camargo, F. D.

Book ID: 121834593
Publisher: American Association for Cancer Research
Year: 2013
Tongue: English
Weight: 159 KB
Volume: 73
Category: Article
ISSN: 0008-5472
DOI: 10.1158/0008-5472.CAN-13-2392

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Hippo pathway in organ size control,

The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal

✍ Zhao, Bin; Tumaneng, Karen; Guan, Kun-Liang 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 506 KB

The Emerging Role of the Hippo Pathway i

The Emerging Role of the Hippo Pathway in Cell Contact Inhibition, Organ Size Control, and Cancer Development in Mammals

✍ Qi Zeng; Wanjin Hong 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Exosomes from ovarian cancer cells induc

Exosomes from ovarian cancer cells induce adipose tissue-derived mesenchymal stem cells to acquire the physical and functional characteristics of tumor-supporting myofibroblasts

✍ Jung Ah Cho; Ho Park; Eun Hye Lim; Kye Hyun Kim; Joong Sub Choi; Jung Hoon Lee; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 870 KB

Overexpression of candidate tumor suppre

Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells

✍ Kondo, Masashi; Ji, Lin; Kamibayashi, Craig; Tomizawa, Yoshio; Randle, Dwight; S 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 190 KB

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB